Skip to main content
Equibles

Salomon & Ludwin, LLC

Position in VRCA — Verrica Pharmaceuticals Inc.

CIK 1766156 RICHMOND, VA
Back to VRCA Full portfolio

Position in VRCA

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$1,774
+$240 QoQ
Shares Held
290
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 43 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in VRCA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Salomon & Ludwin, LLC holds $981,895 across 36 Biotechnology names. VRCA ranks #33 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TGTX
Tg Therapeutics, Inc.
 1,699 $93,343
2 KRYS
Krystal Biotech, Inc.
 227 $84,369
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 159 $78,980
4 CORT
Corcept Therapeutics Inc
 895 $77,820
5 PTGX
Protagonist Therapeutics, Inc
 595 $72,935
6 LGND
Ligand Pharmaceuticals Inc
 200 $63,218
7 PTCT
Ptc Therapeutics, Inc.
 763 $62,237
8 ARGX
Argenx SE
 46 $42,677

All Filings in VRCA

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,774 290
2026-03-31 $1,534 290
2025-12-31 $2,409 290
2025-09-30 $1,249 290
2025-06-30 $1,537 2,900
2025-03-31 $1,281 2,900
2024-12-31 $2,030 2,900
2024-09-30 $4,205 2,900
2024-06-30 $21,141 2,900
2024-03-31 $17,168 2,900
2023-12-31 $21,228 2,900
2023-09-30 $11,266 2,900